Alerts will be sent to your verified email
Verify Email
CORONA
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Corona Remedies is an India-focused branded pharmaceutical formulation company engaged in developing, manufacturing and marketing products in women’s healthcare, cardio-diabeto, pain management, urology and other therapeutic areas. Its diversified product portfolio comprises brands that cater to a range of therapeutic areas such as women’s healthcare, cardio-diabeto, pain management, urology and others/multispecialty pharmaceuticals (comprising vitamins/minerals/nutrition (VMN), gastrointestinal and respiratory.
CORONA Remedies major competitors are Abbott India, Alkem Laboratories, Eris Lifesciences, Glaxosmithkline Phar, JB Chem & Pharma, Mankind Pharma, Pfizer.
Market Cap of CORONA Remedies is ₹11,559 Crs.
While the median market cap of its peers are ₹36,024 Crs.
CORONA Remedies seems to be less financially stable compared to its competitors.
Altman Z score of CORONA Remedies is 14.99 and is ranked 5 out of its 8 competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Jan Feb May | ||||||||||||||||||
| Investor Presentation | Jan Feb May | ||||||||||||||||||
| Conference Call | Jan Feb May | ||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
